DD284600A5 - Zusammensetzung, die auf der oberflaeche von pharmazeutischen granulaten verwendet werden kann - Google Patents

Zusammensetzung, die auf der oberflaeche von pharmazeutischen granulaten verwendet werden kann Download PDF

Info

Publication number
DD284600A5
DD284600A5 DD88315493A DD31549388A DD284600A5 DD 284600 A5 DD284600 A5 DD 284600A5 DD 88315493 A DD88315493 A DD 88315493A DD 31549388 A DD31549388 A DD 31549388A DD 284600 A5 DD284600 A5 DD 284600A5
Authority
DD
German Democratic Republic
Prior art keywords
fat
composition
pharmaceutical
composition according
mixture
Prior art date
Application number
DD88315493A
Other languages
German (de)
English (en)
Inventor
Marttila Esko
Larma Ilkka
Vahervuo Kari
Uotila Jaakko
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD284600A5 publication Critical patent/DD284600A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD88315493A 1987-05-08 1988-05-06 Zusammensetzung, die auf der oberflaeche von pharmazeutischen granulaten verwendet werden kann DD284600A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI872051A FI77573C (fi) 1987-05-08 1987-05-08 Ny konsistens.

Publications (1)

Publication Number Publication Date
DD284600A5 true DD284600A5 (de) 1990-11-21

Family

ID=8524451

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88315493A DD284600A5 (de) 1987-05-08 1988-05-06 Zusammensetzung, die auf der oberflaeche von pharmazeutischen granulaten verwendet werden kann

Country Status (35)

Country Link
US (1) US4935247A (it)
JP (1) JPS63287720A (it)
KR (1) KR880013551A (it)
AT (1) AT396329B (it)
AU (1) AU610161B2 (it)
BE (1) BE1000785A3 (it)
CH (1) CH675070A5 (it)
CS (1) CS270588B2 (it)
DD (1) DD284600A5 (it)
DE (1) DE3815562A1 (it)
DK (1) DK247588A (it)
EG (1) EG18603A (it)
ES (1) ES2006649A6 (it)
FI (1) FI77573C (it)
FR (1) FR2630912B1 (it)
GB (1) GB2204241B (it)
GR (1) GR1000303B (it)
HU (1) HU198621B (it)
IL (1) IL86313A (it)
IS (1) IS3339A7 (it)
IT (1) IT1219691B (it)
LU (1) LU87208A1 (it)
MA (1) MA21264A1 (it)
MX (1) MX167185B (it)
NL (1) NL8801185A (it)
NO (1) NO881993L (it)
NZ (1) NZ224529A (it)
PH (1) PH24652A (it)
PL (1) PL272295A1 (it)
PT (1) PT87429B (it)
RO (1) RO101402B (it)
RU (1) RU1836082C (it)
SE (1) SE8801732L (it)
YU (1) YU46457B (it)
ZA (1) ZA883239B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01299226A (ja) * 1988-05-27 1989-12-04 Seikagaku Kogyo Co Ltd サラゾスルファピリジン腸溶顆粒
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
EP0376331A3 (en) * 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5093128A (en) * 1989-07-18 1992-03-03 Draguesku Oliver J Rumen and other stomach chamber bypass nutrients and methods of fabrication
JP3078859B2 (ja) * 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
EP0689840A1 (de) * 1994-06-28 1996-01-03 Spirig Ag Pharmazeutische Präparate Neues orales Erythromycinbase enthaltendes Arzneimittel
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6242019B1 (en) 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
BRPI0611492B1 (pt) * 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
CA2609617C (en) * 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE835500C (de) * 1950-05-18 1952-03-31 Otto Doerr Dipl Ing Verfahren zum Konservieren eines in einem indifferenten Koerper gespeicherten, im Darm zur Wirkung zu bringenden Mittels
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
GB821790A (en) * 1956-11-20 1959-10-14 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
NL122039C (it) * 1960-10-20
BE636568A (it) * 1961-01-31
BE640616A (it) * 1962-12-19
US3256153A (en) * 1963-02-08 1966-06-14 Smith Kline French Lab Method of stabilizing wax-fat coating materials and product thereof
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
EP0302065B1 (en) * 1986-03-21 1994-08-10 Eurasiam Laboratories, Inc. Pharmaceutical compositions

Also Published As

Publication number Publication date
SE8801732D0 (sv) 1988-05-06
DE3815562A1 (de) 1988-11-24
HUT48458A (en) 1989-06-28
AU1567288A (en) 1988-11-10
BE1000785A3 (fr) 1989-04-04
GR880100297A (en) 1989-02-23
PH24652A (en) 1990-09-07
ES2006649A6 (es) 1989-05-01
EG18603A (en) 1993-06-30
IL86313A0 (en) 1988-11-15
LU87208A1 (fr) 1988-12-13
ZA883239B (en) 1989-07-26
ATA119188A (de) 1992-12-15
RU1836082C (ru) 1993-08-23
DK247588A (da) 1988-11-09
IT1219691B (it) 1990-05-24
MA21264A1 (fr) 1988-12-31
IT8820479A0 (it) 1988-05-06
NZ224529A (en) 1990-02-26
AU610161B2 (en) 1991-05-16
GR1000303B (el) 1992-05-12
NO881993L (no) 1988-11-09
AT396329B (de) 1993-08-25
US4935247A (en) 1990-06-19
GB8810765D0 (en) 1988-06-08
FI872051A (fi) 1988-11-09
FI77573C (fi) 1989-04-10
CH675070A5 (it) 1990-08-31
GB2204241B (en) 1991-02-20
MX167185B (es) 1993-03-09
HU198621B (en) 1989-11-28
PT87429A (pt) 1989-05-31
FI77573B (fi) 1988-12-30
IS3339A7 (is) 1988-08-31
PT87429B (pt) 1992-09-30
FR2630912B1 (fr) 1991-04-12
FR2630912A1 (fr) 1989-11-10
IL86313A (en) 1991-08-16
NO881993D0 (no) 1988-05-06
KR880013551A (ko) 1988-12-21
NL8801185A (nl) 1988-12-01
FI872051A0 (fi) 1987-05-08
RO101402B (ro) 1992-01-13
DK247588D0 (da) 1988-05-06
JPS63287720A (ja) 1988-11-24
SE8801732L (sv) 1988-11-09
CS270588B2 (en) 1990-07-12
YU46457B (sh) 1993-10-20
PL272295A1 (en) 1989-11-13
CS310288A2 (en) 1989-11-14
GB2204241A (en) 1988-11-09
YU83188A (en) 1989-12-31

Similar Documents

Publication Publication Date Title
DD284600A5 (de) Zusammensetzung, die auf der oberflaeche von pharmazeutischen granulaten verwendet werden kann
DE2636152C2 (de) Verfahren zur Herstellung von Dragees
DE60034565T2 (de) Verfahren zur herstellung eines umhüllten geschmackmaskierten granulats mit sofortiger wirkstofffreisetzung
EP0348808B1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung
DE2950977C2 (it)
DE3915150C2 (de) Lang-wirkendes Diclofenac-Natrium-Präparat
DE69721845T2 (de) Orale morphinzubereitung in teilchenform
DE3024858A1 (de) Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials
DE3500103A1 (de) Pharmazeutische zubereitung mit einem in wasser und verdauungssaeften schwer loeslichen wirkstoff
DE3420283A1 (de) Nifedipin-trockenpraeparate und verfahren zu ihrer herstellung
DD298205A5 (de) Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen
DE2518270A1 (de) Verfahren zur herstellung von leicht zerfallenden tabletten
DD298350A5 (de) Verfahren zur herstellung von pharmazeutischen praeparaten mit verzoegerter wirkstoffabgabe
DE2414868B2 (de) Teilchenförmige Arzneimittel
DE3524572A1 (de) Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
CH641357A5 (de) Pharmazeutisches praeparat mit polymerbeschichtungen, enthaltend herzglykoside.
DD238529A5 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit einem gehalt an ibuprofen
CH641358A5 (de) Pharmazeutisches praeparat, enthaltend ein herzglykosid in kombination mit einem polymeren und verfahren zur herstellung desselben.
EP1315481B1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60203178T2 (de) Pharmazeutische formulierung mit überdecktem geschmack und verfahren zu ihrer herstellung
DD209575A5 (de) Verfahren zur herstellung eines pharmazeutischen produktes in anhaltend freisetzender form
DE60033519T2 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
EP1487422B1 (de) Filmüberzüge mit sehr kontrollierter freisetzung und hoher stabilität
DE3404595A1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe
DE2223896A1 (de) Verfahren zum ueberziehen von feinteiligen arzneimitteln

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee